Mark J. Ratain to DNA Primers
This is a "connection" page, showing publications Mark J. Ratain has written about DNA Primers.
Connection Strength
0.121
-
Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis. Br J Cancer. 2006 Sep 04; 95(5):581-6.
Score: 0.064
-
A functional common polymorphism in a Sp1 recognition site of the epidermal growth factor receptor gene promoter. Cancer Res. 2005 Jan 01; 65(1):46-53.
Score: 0.057